Silence Therapeutics reported $-0.09 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.





Eps Change Date
AstraZeneca USD 2.12 0.26 Dec/2025
Autolus Therapeutics Ltd USD -0.34 0.04 Dec/2025
Hikma Pharmaceutical USD 0.65 0.12 Dec/2025
Novartis USD 1.54 0.5 Dec/2025
Roche Holding CHF 8.37 2.95 Dec/2025
Silence Therapeutics USD -0.09 0.01 Mar/2026